Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia by Boulos Nidal, Mulder Heather L, Calabrese Christopher R, Morrison Jeffrey B, Rehg Jerold E, Relling Mary V, Sherr Charles J, Williams Richard T in Blood (2011).

[PMID: 21263154] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.